Announcements Trials
Browse Landscape

Phase

Phase NA 29Phase 2 6Phase 1 4Phase EARLY_PHASE1 2Phase 1/2 2Phase 3 1

Status

Recruiting 4Not yet recruiting 1Completed 1

Sponsor Class

OTHER 4INDUSTRY 2

Study Type

Interventional 6

Sponsor

Cancer Type

Gynecologic 6

Conditions

Breast Neoplasms 558Carcinoma, Non-Small-Cell Lung 514Prostatic Neoplasms 336Colorectal Neoplasms 273Neoplasms 269Multiple Myeloma 267Leukemia, Myeloid, Acute 225Squamous Cell Carcinoma of Head and Neck 217Lung Neoplasms 210Neoplasm Metastasis 205Carcinoma, Hepatocellular 198Melanoma 175Triple Negative Breast Neoplasms 174Pancreatic Neoplasms 171Recurrence 153Ovarian Neoplasms 152Lymphoma 142Glioblastoma 136Brain Neoplasms 134Sarcoma 131Carcinoma, Renal Cell 128Lymphoma, Large B-Cell, Diffuse 126Leukemia, Lymphocytic, Chronic, B-Cell 126Head and Neck Neoplasms 124Stomach Neoplasms 123Precursor Cell Lymphoblastic Leukemia-Lymphoma 110Rectal Neoplasms 109Myelodysplastic Syndromes 104Uterine Cervical Neoplasms 100Urinary Bladder Neoplasms 100

Interventions

pembrolizumab 1epigallocatechin gallate 1artesunic acid 1artemisinin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Phase 2 × Uterine Cervical Dysplasia × 1 year × Clear all
NCT07545746 2026-06-02

ASCEND

UNC Lineberger Comprehensive Cancer Center

Phase 2 Not yet recruiting
140 enrolled
Gynecologic

Uterine Cervical Dysplasia, Uterine Cervical Neoplasms, HIV Infections, Papillomavirus Infections

NCT06519994 2026-05-14

Feasibility of Intravaginal Artesunate as Adjuvant HPV & Cervical Precancer Treatment in Kenya

UNC Lineberger Comprehensive Cancer Center

Phase 2 Completed
120 enrolled
Gynecologic

Acquired Immunodeficiency Syndrome, Uterine Cervical Dysplasia

NCT07572396 2026-05-14

Phase II Study of Dysplasixâ„¢ Intravaginal Suppositories in Patients Patients With High-Risk HPV and Mild Cervical Cytologic Abnormalities

Amplexd Therapeutics, Inc.

Phase 2 Recruiting
45 enrolled
Gynecologic

Squamous Intraepithelial Lesions, Uterine Cervical Dysplasia, Papillomavirus Infections, Atypical Squamous Cells of the Cervix

NCT07454915 2026-05-06

PVX4 for the Treatment of Human Papilloma Virus (HPV)16+ Cervical Dysplasia

PapiVax Biotech, Inc.

Phase 2 Recruiting
138 enrolled
Gynecologic

Uterine Cervical Dysplasia

NCT04712851 2026-03-10

Pembrolizumab for the Treatment of Cervical Intraepithelial Neoplasia

Jonsson Comprehensive Cancer Center

Phase 2 Recruiting
25 enrolled
Gynecologic

Uterine Cervical Dysplasia

NCT04098744 2025-10-02

ART-CIN_IIB

Frantz Viral Therapeutics, LLC

Phase 2 Recruiting
78 enrolled
Gynecologic

Uterine Cervical Dysplasia, Papillomavirus Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡